E.B. Lansdon

1.4k total citations
21 papers, 1000 citations indexed

About

E.B. Lansdon is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, E.B. Lansdon has authored 21 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Virology and 9 papers in Epidemiology. Recurrent topics in E.B. Lansdon's work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). E.B. Lansdon is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). E.B. Lansdon collaborates with scholars based in United States, South Korea and Czechia. E.B. Lansdon's co-authors include Xiaohong Liu, Magdeleine Hung, Nilima Kutty, Katherine M. Brendza, Andrew J. Fisher, Irwin H. Segel, Susmith Mukund, Gabriel Birkuš, Ruth Wang and Debi Jin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

E.B. Lansdon

20 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.B. Lansdon United States 16 649 552 441 189 169 21 1000
Henry J. Breslin United States 17 756 1.2× 649 1.2× 519 1.2× 525 2.8× 150 0.9× 27 1.4k
Aravind Basavapathruni United States 16 341 0.5× 283 0.5× 933 2.1× 137 0.7× 97 0.6× 25 1.4k
Piet Wigerinck Belgium 19 1.1k 1.7× 768 1.4× 438 1.0× 439 2.3× 421 2.5× 44 1.8k
Michael L. Moore United States 13 600 0.9× 558 1.0× 419 1.0× 274 1.4× 85 0.5× 17 1.0k
Tong Zhao China 20 312 0.5× 240 0.4× 335 0.8× 260 1.4× 188 1.1× 43 889
Diane Thibeault Canada 19 794 1.2× 502 0.9× 317 0.7× 145 0.8× 396 2.3× 30 1.4k
S. Pazhanisamy United States 14 335 0.5× 305 0.6× 477 1.1× 200 1.1× 74 0.4× 23 942
Sena Garber United States 17 563 0.9× 496 0.9× 340 0.8× 431 2.3× 91 0.5× 23 1.1k
Ginette McKercher Canada 14 502 0.8× 244 0.4× 196 0.4× 164 0.9× 288 1.7× 30 982

Countries citing papers authored by E.B. Lansdon

Since Specialization
Citations

This map shows the geographic impact of E.B. Lansdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.B. Lansdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.B. Lansdon more than expected).

Fields of papers citing papers by E.B. Lansdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.B. Lansdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.B. Lansdon. The network helps show where E.B. Lansdon may publish in the future.

Co-authorship network of co-authors of E.B. Lansdon

This figure shows the co-authorship network connecting the top 25 collaborators of E.B. Lansdon. A scholar is included among the top collaborators of E.B. Lansdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.B. Lansdon. E.B. Lansdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Qing, Alexandre Mercier, A. Nayak, et al.. (2025). Structural and mechanistic insights into herpesvirus helicase–primase and its therapeutic inhibitors. Nature Microbiology. 10(12). 3191–3201.
2.
Baszczyňski, Ondřej, Martin Kaiser, Martin Dračínský, et al.. (2023). Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties. Journal of Medicinal Chemistry. 66(3). 1761–1777. 11 indexed citations
3.
Hung, Magdeleine, et al.. (2019). Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance. Communications Biology. 2(1). 20 indexed citations
4.
Šimon, Petr, Ondřej Baszczyňski, David Šaman, et al.. (2016). Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1. European Journal of Medicinal Chemistry. 122. 185–195. 14 indexed citations
5.
Currie, Kevin, Jeffrey E. Kropf, Peter Blomgren, et al.. (2014). Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase. Journal of Medicinal Chemistry. 57(9). 3856–3873. 131 indexed citations
6.
Parrish, Jay P., L. Tong, Michael Wang, et al.. (2012). Synthesis and biological evaluation of phosphonate analogues of nevirapine. Bioorganic & Medicinal Chemistry Letters. 23(5). 1493–1497. 21 indexed citations
7.
Tsiang, Manuel, G.S. Jones, Anita Niedziela‐Majka, et al.. (2012). New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action. Journal of Biological Chemistry. 287(25). 21189–21203. 129 indexed citations
8.
Kulkarni, Rima, Kerim Babaoglu, E.B. Lansdon, et al.. (2011). The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 47–54. 69 indexed citations
9.
White, Kirsten, James Chen, E.B. Lansdon, et al.. (2011). Mechanism of Resistance to GS-9148 Conferred by the Q151L Mutation in HIV-1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 55(6). 2662–2669. 8 indexed citations
10.
Lansdon, E.B., Katherine M. Brendza, Magdeleine Hung, et al.. (2010). Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design. Journal of Medicinal Chemistry. 53(10). 4295–4299. 191 indexed citations
11.
Mitchell, Michael L., Jong Chan Son, Hongyan Guo, et al.. (2010). N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1589–1592. 12 indexed citations
12.
Lansdon, E.B., Dharmaraj Samuel, Leanna Lagpacan, et al.. (2010). Visualizing the Molecular Interactions of a Nucleotide Analog, GS-9148, with HIV-1 Reverse Transcriptase–DNA Complex. Journal of Molecular Biology. 397(4). 967–978. 37 indexed citations
13.
Mitchell, Michael L., Jong Chan Son, Ill Young Lee, et al.. (2010). N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1585–1588. 19 indexed citations
14.
Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2009). Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex. Journal of Biological Chemistry. 284(48). 33580–33599. 40 indexed citations
15.
O’Neal, Wesley T., Kirsten White, Charles Wakeford, et al.. (2009). Mutations in the thumb–connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients. Antiviral Therapy. 14(2). 231–239. 19 indexed citations
16.
Kirschberg, Thorsten, M. Balakrishnan, Neil Squires, et al.. (2009). RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information. Journal of Medicinal Chemistry. 52(19). 5781–5784. 86 indexed citations
17.
Kirschberg, Thorsten, M. Balakrishnan, Wei Huang, et al.. (2007). Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis. Bioorganic & Medicinal Chemistry Letters. 18(3). 1131–1134. 36 indexed citations
18.
Yu, Zhihao, E.B. Lansdon, Irwin H. Segel, & Andrew J. Fisher. (2006). Crystal Structure of the Bifunctional ATP Sulfurylase – APS kinase from the Chemolithotrophic Thermophile Aquifex aeolicus. Journal of Molecular Biology. 365(3). 732–743. 29 indexed citations
19.
20.
Lansdon, E.B., Irwin H. Segel, & Andrew J. Fisher. (2002). Ligand-Induced Structural Changes in Adenosine 5‘-Phosphosulfate Kinase from Penicillium chrysogenum,. Biochemistry. 41(46). 13672–13680. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry J. Breslin Breakdown of academic impact, for papers by Aravind Basavapathruni Breakdown of academic impact, for papers by Piet Wigerinck Breakdown of academic impact, for papers by Michael L. Moore Breakdown of academic impact, for papers by Tong Zhao Breakdown of academic impact, for papers by Diane Thibeault Breakdown of academic impact, for papers by S. Pazhanisamy Breakdown of academic impact, for papers by Sena Garber Breakdown of academic impact, for papers by Ginette McKercher
Rankless by CCL
2026